WesBanco Inc/ US9508101014 /
30/05/2024 21:55:37 | Chg. +0.5300 | Volume | Bid21:56:47 | Demandez à21:56:47 | Haut | Bas |
---|---|---|---|---|---|---|
27.2100USD | +1.99% | 69,039 Chiffrre d'affaires: 902,192.9212 |
27.2100Bid taille: 300 | 27.2200Ask la taille: 200 | 27.3600 | 26.8875 |
GlobeNewswire
22:10
Collective Audience Receives Additional Nasdaq Notification Regarding Continued Listing Requirements
GlobeNewswire
22:10
Kimco Realty® Management to Present at Nareit’s REITweek: 2024 Investor Conference
GlobeNewswire
22:05
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
22:05
IndyCar Driver Marcus Armstrong to Represent Root Insurance at Detroit Grand Prix
GlobeNewswire
22:05
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of P...
GlobeNewswire
22:05
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedr...
GlobeNewswire
22:05
Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
GlobeNewswire
22:05
Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Stu...
GlobeNewswire
22:05
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
GlobeNewswire
22:05
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq ...
GlobeNewswire
22:05
NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024
GlobeNewswire
22:05
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page